Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds.BMJ. 2020 06 08; 369:m2263.BMJ
Links
Pub Type(s)
Journal Article
Language
eng
PubMed ID
32513810
Citation
Torjesen, Ingrid. "Covid-19: Hydroxychloroquine Does Not Benefit Hospitalised Patients, UK Trial Finds." BMJ (Clinical Research Ed.), vol. 369, 2020, pp. m2263.
Torjesen I. Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds. BMJ. 2020;369:m2263.
Torjesen, I. (2020). Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds. BMJ (Clinical Research Ed.), 369, m2263. https://doi.org/10.1136/bmj.m2263
Torjesen I. Covid-19: Hydroxychloroquine Does Not Benefit Hospitalised Patients, UK Trial Finds. BMJ. 2020 06 8;369:m2263. PubMed PMID: 32513810.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds.
A1 - Torjesen,Ingrid,
Y1 - 2020/06/08/
PY - 2020/6/10/entrez
PY - 2020/6/10/pubmed
PY - 2020/6/10/medline
SP - m2263
EP - m2263
JF - BMJ (Clinical research ed.)
JO - BMJ
VL - 369
SN - 1756-1833
UR - https://www.unboundmedicine.com/medline/citation/32513810/Covid_19:_Hydroxychloroquine_does_not_benefit_hospitalised_patients_UK_trial_finds_
DB - PRIME
DP - Unbound Medicine
ER -
Latest evidence on COVID-19 from PubMed, WHO, CDC.
Visit free Relief Central.
Visit free Relief Central.
Try the Free App:
